Related Experiment Videos
C-reactive protein (CRP) in the cardiovascular system
1Department of General Medicine, Gunma University School of Medicine, Maebashi 371-8511.
Rinsho Byori. the Japanese Journal of Clinical Pathology
|June 8, 2001
Summary
C-reactive protein (CRP) indicates inflammation and is linked to coronary artery disease (CAD) risk. Measuring CRP aids in diagnosing heart conditions like dilated cardiomyopathy (DCM) and guiding treatment strategies.
Area of Science:
- Biochemistry
- Cardiology
- Immunology
Background:
- C-reactive protein (CRP) is an acute-phase reactant elevated during inflammation.
- Chronic inflammation plays a key role in the pathogenesis of atherosclerosis.
- Elevated CRP levels are associated with an increased risk of coronary artery disease (CAD).
Purpose of the Study:
- To review the literature on C-reactive protein (CRP) in relation to coronary artery disease (CAD).
- To explore the utility of CRP measurement in diagnosing and managing cardiovascular disorders, including dilated cardiomyopathy (DCM).
Main Methods:
- Literature review of studies investigating CRP in CAD and other cardiovascular conditions.
- Analysis of CRP's role as an inflammatory marker in myocardial damage and heart failure.
Main Results:
- CRP is present in human atherosclerotic lesions, highlighting inflammation's role.
- Elevated CRP levels correlate with a higher risk of future CAD events.
- CRP measurement is valuable for identifying high-risk patients with DCM and lymphocytic myocarditis.
Conclusions:
- Focusing on inflammation is critical for atherosclerosis research.
- Circulating CRP measurement can aid in the diagnosis of cardiovascular disorders.
- CRP levels can inform the selection of therapeutic strategies for cardiovascular conditions.